Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)

The requested reference [3c1707d671559dfddf9ed71be64c13312435c3fc] no longer exists in our database. It has been replaced by the current reference: [fde269c4f9d23309a7c8661b20db7ff5e6fcaa80]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Eligible participants will be randomly assigned to receive anisodine hydrobromide ormatching placebo in addition to standard care, with efficacy and safety assessed duringfollow‐up.
Epistemonikos ID: 0e3bdd516c3380fecfbea3b404528d2ce83a7c90
First added on: Sep 03, 2026